10 completed. 4 Phase 3, 3 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Not applicable | 3 | Completed 3 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow frovatriptan: new trials by email Literature Review of frovatriptan trials Research Report on frovatriptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| New Technologies in the Rehabilitation of Chronic Stroke Rehabilitation technology - Stroke, Hemiplegia | Not applicable | Completed | Markus Wirz | 15 | 2018-08-31 | 2022-09-27 |
| Frovatriptan as a Transitional Therapy in Medication Overuse Headache Frovatriptan, Placebo - Medication Overuse Headache, Analgesic Overuse Headache | Phase 2 | Completed | University of Calgary | 55 | 2010-01-01 | 2019-04-18 |
| Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine topiramate, frovatriptan - Migraine | Phase 4 | Completed | Clinvest | 55 | 2009-08-01 | 2012-01-13 |
| Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals frovatriptan, placebo - Migraines, Bleeding | Not applicable | Completed | Scott and White Hospital & Clinic | 30 | 2008-06-01 | 2011-07-25 |
| A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting Frovatriptan, Placebo - Migraine | Not applicable | Completed | Thomas Jefferson University | 74 | 2007-07-01 | 2011-05-26 |
| A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine Frovatriptan - Migraine | Phase 3 | Completed | SK Chemicals Co., Ltd. | 298 | 2006-11-01 | 2013-04-18 |
| Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine Frovatriptan, Usual Care - Menstrual Migraine (MM) Headaches | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 192 | 2005-09-01 | 2010-02-15 |
| A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine Frovatriptan 2.5mg QD, Frovatriptan 2.5 mg BID, placebo - Migraine | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 500 | 2004-10-01 | 2024-01-02 |
| Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches Frovatriptan 2.5 mg - Migraine | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 550 | 2003-12-01 | 2024-01-02 |
| A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine Frovatriptan, Placebo - Menstrually Associated Migraine | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 579 | 2001-06-01 | 2024-01-02 |
Migraine Disorders (8) · Headache (2) · Headache Disorders, Secondary (1) · Hemiplegia (1) · Hemorrhage (1) · Limb-girdle muscular dystrophy, type 2C (1) · Metrorrhagia (1) · Stroke (1)
Endo USA Inc., a Keenova Therapeutics Company (4) · Clinvest (1) · Markus Wirz (1) · SK Chemicals Co., Ltd. (1) · Scott and White Hospital & Clinic (1) · Thomas Jefferson University (1) · University of Calgary (1)
United States (5) · Canada (1) · Germany (1) · Hungary (1) · Poland (1) · South Africa (1) · Switzerland (1) · United Kingdom (1)
Anne MacGregor, DIPM MFFP (1) · Arthur Elkind, MD (1) · Farnaz Amoozegar, MD, FRCPC (1) · Patricia Sulak, MD (1) · Roger K Cady, MD (1) · Stephen D. Silberstein, M.D. (1) · Sun U Kwon, professor (1) · Werner J Becker, MD, FRCPC (1)